Hyperactivation of the Wnt pathway is common in breast carcinomas where it is often activated in the absence of downstream mutations [4], and Wnt1 overexpression in mammary epithelium is sufficient to form basal-like tumors in mice with low metastatic potential [5]. Here, WNT1 is linked to breast carcinoma.